Literature DB >> 7591188

Mortality study of employees engaged in the manufacture and use of hydroquinone.

J W Pifer1, F T Hearne, F A Swanson, J L O'Donoghue.   

Abstract

Mortality in a 1942-1990 cohort of 858 men and 21 women employed in the manufacture and use of hydroquinone was evaluated through 1991. Average exposure concentrations, 1949-1990, ranged from 0.1 to 6.0 mg/m3 for hydroquinone dust and from less than 0.1 to 0.3 for quinone vapor (estimated 8-h time-weighted averages). Compared with general population and occupational referents, there were statistically significant deficits in total mortality and deaths due to cancer. No significant excesses were observed for such hypothesized causes as kidney cancer [2 observed vs 1.3 expected (both control groups), P approximately 0.39], liver cancer (0 vs 0.8, 1.3), and leukemia (0 vs 2.3, 2.7). Dose-response analyses of selected causes of death, including renal carcinoma, demonstrated no statistically significant heterogeneities or linear trends according to estimated career hydroquinone exposure (mg/m3-years) or time from first exposure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591188     DOI: 10.1007/BF00409409

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  69 in total

1.  Corneal changes from quinone-hydroquinone exposure.

Authors:  B ANDERSON; F OGLESBY
Journal:  AMA Arch Ophthalmol       Date:  1958-04

2.  Allergy and occupational exposure to hydroquinone and to methionine.

Authors:  D Choudat; F Neukirch; P Brochard; G Barrat; J Marsac; F Conso; M Philbert
Journal:  Br J Ind Med       Date:  1988-06

3.  Occupational vitiligo.

Authors:  M Das; A Tandon
Journal:  Contact Dermatitis       Date:  1988-03       Impact factor: 6.600

4.  A Mantel-Haenszel statistic for testing the association between a polychotomous exposure and a rare outcome.

Authors:  T Hakulinen
Journal:  Am J Epidemiol       Date:  1981-02       Impact factor: 4.897

5.  Risk factors for kidney cancer in New South Wales. IV. Occupation.

Authors:  M McCredie; J H Stewart
Journal:  Br J Ind Med       Date:  1993-04

6.  A population--based case--control study of renal cell carcinoma.

Authors:  J K McLaughlin; J S Mandel; W J Blot; L M Schuman; E S Mehl; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1984-02       Impact factor: 13.506

7.  Benzene and its phenolic metabolites produce oxidative DNA damage in HL60 cells in vitro and in the bone marrow in vivo.

Authors:  P Kolachana; V V Subrahmanyam; K B Meyer; L Zhang; M T Smith
Journal:  Cancer Res       Date:  1993-03-01       Impact factor: 12.701

8.  Analgesics and tobacco as risk factors for cancer of the ureter and renal pelvis.

Authors:  M McCredie; J H Stewart; J M Ford
Journal:  J Urol       Date:  1983-07       Impact factor: 7.450

9.  Associations between several sites of cancer and twelve petroleum-derived liquids. Results from a case-referent study in Montreal.

Authors:  J Siemiatycki; R Dewar; L Nadon; M Gérin; L Richardson; S Wacholder
Journal:  Scand J Work Environ Health       Date:  1987-12       Impact factor: 5.024

10.  Occupational dermatoses at a film laboratory. Follow-up after modernization.

Authors:  C Lidén
Journal:  Contact Dermatitis       Date:  1989-03       Impact factor: 6.600

View more
  3 in total

Review 1.  Comprehensive evaluation of long-term trends in occupational exposure: Part 1. Description of the database.

Authors:  E Symanski; L L Kupper; S M Rappaport
Journal:  Occup Environ Med       Date:  1998-05       Impact factor: 4.402

2.  Free-radicals and advanced chemistries involved in cell membrane organization influence oxygen diffusion and pathology treatment.

Authors:  Richard C Petersen
Journal:  AIMS Biophys       Date:  2017-04-06

3.  Advancements in Free-Radical Pathologies and an Important Treatment Solution with a Free-Radical Inhibitor.

Authors:  R C Petersen; M S Reddy; P-R Liu
Journal:  SF J Biotechnol Biomed Eng       Date:  2018-02-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.